Lars Hufnagel will be responsible for advancing VERAXA’s antibody screening and ADC technologies by further developing its droplet-based microfluidic screening technology.HEIDELBERG, Germany, March 14, 2022 / B3C newswire / Dr. Lars Hufnagel has been appointed Chief Technical Officer (CTO) of VERAXA Biotech, base.